About Taryn

Taryn Barker is the Director of the Viral Hepatitis Program at the Clinton Health Access Initiative. She has led the launch of the hepatitis program in seven countries in Africa and Asia. During her previous roles at CHAI, Ms. Barker has supported governments in strategic planning, budgeting, cost optimization and grant development for HIV, malaria elimination, maternal health, TB, and nursing workforce expansion.   Prior to CHAI, Ms. Barker worked in management consulting at Deloitte where she specialized in supporting governments and small and medium-sized enterprises develop their markets, as well as in investor relations and banking. She holds a Masters in Science in Health Economics and Policy from the London School of Economics and a Bachelor of Commerce in Finance and Strategic Management from McGill University. 

This speaker will be presenting at the following session(s)

  • Strategic direction 4: different financing mechanisms for viral hepatitis programmes

    Golden Hall

    Day: 3 November

    Time: 11:00

    This session examines potential hepatitis financing mechanisms that will be required for countries to launch, accelerate and sustain public health responses to viral hepatitis.

    Chairs: Dr Adele Benzaken, Ministry of Health, Brazil

    Presentations:

    • From economic analysis to financial dialogue.
      Dr. Homie Razavi, Center for Disease Analysis
    • A new Fund for Elimination of Viral Hepatitis: EndHEP2030.
      Wangsheng Li, Zeshan Foundation
    • Getting started with funding: catalytic initiatives.
      Taryn Barker, Clinton Health Access Initiative
    • Engaging Ministries of Finance.
      Eduardo González-Pier, Center for Global Development
    • Domestic funding.
    • Q & A session.

    Session objectives:

    • Understand the global investment case and its use in attracting donors.
    • Learn how to ensure the support of Ministries of Finance.
    • Understand how the public and private sector can be combined.
    • Discover how 3 countries have approached hepatitis financing.